5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 97.69▼ | 97.75▼ | 98.19▼ | 91.24▲ | 88.79▲ |
MA10 | 97.36▲ | 98.20▼ | 96.73▲ | 86.02▲ | 77.52▲ |
MA20 | 97.84▼ | 96.65▲ | 94.41▲ | 86.47▲ | 71.04▲ |
MA50 | 97.83▼ | 93.56▲ | 89.10▲ | 74.91▲ | 62.18▲ |
MA100 | 95.71▲ | 88.30▲ | 87.39▲ | 69.53▲ | N/A |
MA200 | 93.26▲ | 87.17▲ | 87.53▲ | 64.63▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.005▼ | -0.176▼ | 0.076▲ | 0.440▲ | N/A |
RSI | 48.038▼ | 57.323▲ | 60.274▲ | 63.678▲ | N/A |
STOCH | 72.575 | 59.084 | 85.052▲ | 67.766 | 49.911 |
WILL %R | -40.700 | -29.450 | -14.583▲ | -10.034▲ | -39.396 |
CCI | 1.380 | -3.520 | 52.294 | 137.891▲ | 92.596 |
Wednesday, January 13, 2021 11:13 AM
IGM Biosciences, Inc. (NASDAQ:IGMS) has earned an average recommendation of “Buy” from the ten research firms that are currently covering the stock, MarketBeat reports. One analyst has rated the stock ...
|
Tuesday, January 12, 2021 04:44 AM
Medivir AB enters exclusive licensing agreement, through which IGM Biosciences (NASDAQ:IGMS), will receive global development rights for birinapant, a clinical-stage SMAC mimetic ...
|
Monday, January 11, 2021 03:00 PM
IGM Biosciences, Inc. today announced that it has entered into an exclusive license agreement with Medivir AB, through which IGM will receive global, exclusive development and commercialization rights ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/01/21 | 93.10 | 99.548 | 93.10 | 97.15 | 142,900 |
14/01/21 | 91.22 | 98.47 | 86.081 | 94.47 | 253,700 |
13/01/21 | 90.33 | 94.82 | 87.51 | 88.10 | 137,700 |
12/01/21 | 86.49 | 93.95 | 84.315 | 91.14 | 219,800 |
11/01/21 | 83.09 | 86.14 | 81.96 | 85.34 | 146,798 |
08/01/21 | 84.71 | 88.10 | 80.26 | 84.72 | 215,500 |
07/01/21 | 81.32 | 83.87 | 80.69 | 83.04 | 142,400 |
06/01/21 | 79.76 | 81.72 | 76.60 | 79.81 | 174,400 |
05/01/21 | 77.48 | 79.86 | 76.43 | 79.12 | 202,094 |
04/01/21 | 88.07 | 88.95 | 75.65 | 77.27 | 297,000 |
|
|
||||
|
|
||||
|
|